Sec. Multiple Sclerosis and Neuroimmunology
This article is part of the Research Topic
Immune-mediated Disorders of the Spinal Cord: Diagnosis, Treatment Strategies, and Outcomes in the 21st Century
NEUROIMAGING FEATURES IN INFLAMMATORY MYELOPATHIES: A REVIEW
- 1Department of Neurology, Mayo Clinic, United States
- 2Neuroimaging Research Unit, Division of Neuroscience; IRCCS San Raffaele Scientific Institute, Italy
- 3Vita-Salute San Raffaele University, Italy
- 4Neurology Unit, Department of Medical, Surgical and Experimental Sciences; University of Sassari, Italy, Italy
- 5Neurology Unit, IRCCS San Raffaele Scientific Institute, Italy
- 6Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Italy
- 7Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Italy
- 8Laboratory Medicine and Pathology, Mayo Clinic, United States
Spinal cord involvement can be observed in the course of immune-mediated disorders. Although multiple sclerosis (MS) represents the leading cause of inflammatory myelopathy, an increasing number of alternative etiologies must be now considered in the diagnostic work-up of patients presenting with transverse myelitis. These include antibody-mediated disorders and cytotoxic T cell-mediated targeting central nervous system (CNS) antigens, and systemic autoimmune conditions with secondary CNS involvement. Even though clinical features are helpful to orient the diagnostic suspicion (e.g., timing and severity of myelopathy symptoms), the differential diagnosis of inflammatory myelopathies is often challenging due to overlapping features. Moreover, noninflammatory etiologies can sometimes mimic an inflammatory process. In this setting, magnetic resonance imaging (MRI) is becoming a fundamental tool for the characterization of spinal cord damage, revealing a pictorial scenario which is wider than the clinical manifestations. The characterization of spinal cord lesions in terms of longitudinal extension, location on axial plane, involvement of the white matter and/or gray matter, and specific patterns of contrast enhancement, often allows a proper differentiation of these diseases. For instance, besides classical features, such as the presence of longitudinally extensive spinal cord lesions in patients with aquaporin-4-IgG positive neuromyelitis optica spectrum disorder (AQP4+NMOSD), novel radiological signs (e.g., H sign, trident sign) have been recently proposed and successfully applied for the differential diagnosis of inflammatory myelopathies.
In this review article, we will discuss the radiological features of spinal cord involvement in autoimmune disorders such as MS, AQP4+NMOSD, myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), and other recently characterized immune-mediated diseases. The identification of imaging pitfalls and mimics that can lead to misdiagnosis will also be examined.
Since spinal cord damage is a major cause of irreversible clinical disability, the recognition of these radiological aspects will help clinicians achieve a correct and prompt diagnosis, treat early with disease-specific treatment and improve patient outcomes.
Keywords: Myelopathies1, MRI2, Neuromyelitis optica spectrum disorders3, Multiple sclerosis5, Myelin olgiodendrocyte glycoprotein, Paraneoplastic, Transverse myelitis
Received: 13 Jul 2022;
Accepted: 16 Aug 2022.
Copyright: © 2022 Cacciaguerra, Sechi, Rocca, Filippi, Pittock and Flanagan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Prof. Eoin P. Flanagan, Department of Neurology, Mayo Clinic, Rochester, United States